Author

April Naegeli 1

1 Eli Lilly and Company,Indianapolis,United States

ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH IMPROVEMENTS IN CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING MIRIKIZUMAB

Marla C. Dubinsky, Remo Panaccione, James D Lewis, Bruce E. Sands, Toshifumi Hibi, Scott D. Lee, April Naegeli, Mingyang Shan, Linden Green, Nathan Morris, Vipin Arora, Alison Potts Bleakman, Ruth Belin, Simon Travis

ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH SIGNIFICANTLY IMPROVED INFLAMMATORY BOWEL DISEASE RELATED QUALITY OF LIFE IN A PHASE 2 TRIAL OF MIRIKIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS

Marla C. Dubinsky, Scott D. Lee, Remo Panaccione, Maria T. Abreu, Severine Vermeire, Trevor Lissoos, Nathan Morris, Vipin Arora, Mingyang Shan, April Naegeli, Bruce E. Sands

Biologic Use in Adult Patients Newly Diagnosed with Crohn's Disease in the United States, 2010-2013 and 2014-2016

Geert R. D'Haens, April Naegeli, Malika Mahoui, Stuart Morton, Yan Dong, Theresa Hunter, Mallory Farrar, James Canavan, Diana Stefani-Hunyady

BIOLOGIC USE IN ADULT PATIENTS NEWLY DIAGNOSED WITH CROHN'S DISEASE IN THE UNITED STATES, 2010-2013 AND 2014-2016

April Naegeli

Biologic Use in Adult Patients Newly Diagnosed with Ulcerative Colitis in the United States, 2010-2013 and 2014-2016

Geert R. D'Haens, April Naegeli, Malika Mahoui, Stuart Morton, Yan Dong, Theresa Hunter, Mallory Farrar, James Canavan, Diana Stefani-Hunyady

BIOLOGIC USE IN ADULT PATIENTS NEWLY DIAGNOSED WITH ULCERATIVE COLITIS IN THE UNITED STATES, 2010-2013 AND 2014-2016

April Naegeli

BIOMARKERS AND BOWEL URGENCY IN RESPONSE TO MIRIKIZUMAB FOR ULCERATIVE COLITIS

Marla C. Dubinsky, April Naegeli, Mingyang Shan, Sylvie Bradesi, Jochen Schmitz, Catherine Milch, Cem Kayhan, Simon Travis

CHANGE IN URGENCY AMONG CROHN’S DISEASE PATIENTS: ANALYSES FROM THE SPARC IBD

Mingyang Shan, Xian Zhou, Theresa Hunter, April Naegeli, James D. Lewis

CHARACTERISTICS OF ULCERATIVE COLITIS PATIENTS BY URGENCY OF DEFECATION AT ENROLLMENT IN THE CORRONA INFLAMMATORY BOWEL DISEASE REGISTRY

Douglas C. Wolf, April Naegeli, Mingyang Shan, Theresa Hunter Gibble, Angelina Sontag, Page Moore, Rachel Mackey, Margaux Crabtree, Raymond Cross

EFFECT OF 52 WEEKS OF MIRIKIZUMAB ON INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE SCORES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

Laurent Peyrin-Biroulet, Bruce E. Sands, William Sandborn, Peter D.R. Higgins, Fumihito Hirai, Vipul Jairath, Ruth Belin, Yan Dong, Elisa Gomez Valderas, Debra Miller, Vipin Arora, April Naegeli, Paul Pollack, Jay Tuttle, Toshifumi Hibi

Item 1 - 10 / 23
1
2 3